HB Wealth Management LLC lowered its position in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) by 5.3% in the ...
Edwards Lifesciences (EW) stock faces a downgrade at Wolfe due to concerns over its TAVR market prospects. Read more here.
Edwards Lifesciences' Business In-Depth With that ... surgical clips and inserts. The HemoSphere monitoring platform displays valuable physiological information. Edwards’ latest algorithm ...
Edwards Lifesciences EW is developing the most comprehensive structural heart disease portfolio post the sell-off of the Critical Care wing. The Surgical Structural Heart business is benefiting ...